Fortress, Urica Dose First Patients In Ph3 Dotinurad Gout Trial
21 Oct 2025 //
GLOBENEWSWIRE
Crystalys Therapeutics Progresses Dotinurad Phase 3 Trials
21 Oct 2025 //
PR NEWSWIRE
Fortress Biotech And Urica Therapeutics Unveil Crystalys
01 Oct 2025 //
GLOBENEWSWIRE
Crystalys Launches with $205M Funding for Gout Drug Trials
30 Sep 2025 //
REUTERS

Market Place
Sourcing Support